{"id":316,"date":"2013-12-15T13:08:02","date_gmt":"2013-12-15T13:08:02","guid":{"rendered":"http:\/\/www.dralexurology.com\/bladder-cancer\/?p=316"},"modified":"2013-10-27T02:23:46","modified_gmt":"2013-10-27T02:23:46","slug":"benefit-neoadjuvant-chemo-micropapillary-bladder-cancer","status":"publish","type":"post","link":"http:\/\/www.dralexurology.com\/bladder-cancer\/news\/benefit-neoadjuvant-chemo-micropapillary-bladder-cancer\/","title":{"rendered":"Benefit of Neoadjuvant Chemo in Micropapillary Bladder Cancer"},"content":{"rendered":"<p>Micro-papillary bladder cancer is a very aggressive subtype of transitional cell carcinoma of the bladder that typically presents with very advanced disease and progresses fast.<\/p>\n<p>Due to fast progression of the disease a question of whether neoadjuvant chemotherapy is beneficial has been raised as delaying surgical treatment may predispose to disease progression.<\/p>\n<p>A new small study suggests that muscle invasive micropapillary bladder cancer responds to neoadjuvant therapy and those patients who respond to the neoadjuvant therapy show improved outcomes.<\/p>\n<p>At this point given our knowledge of the benefit of neoadjuvant chemotherapy in classical muscle invasive transitional cell carcinoma of the bladder and the new data, <strong>it appears that it is probably advantageous whenever possible to administer neoadjuvant chemotherapy before definitive surgical treatment for muscle invasive micropapillary bladder cancer with early radical cystectomy.<\/strong><\/p>\n<p>The question remains whether noninvasive micropapillary bladder cancer which is also typically treated by early cystectomy would benefit from neoadjuvant therapy.\u00a0 Based on disease aggressiveness and our knowledge of tumor biology my guess would be that it would be advantageous for patients to receive new adjuvant therapy in this setting as well.<\/p>\n<p><strong>References:<\/strong><\/p>\n<p><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23384236\">http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23384236<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Micro-papillary bladder cancer is a very aggressive subtype of transitional cell carcinoma of the bladder that typically presents with very advanced disease and progresses fast. Due to fast progression of the disease a question of whether neoadjuvant chemotherapy is beneficial has been raised as delaying surgical treatment may predispose to disease progression. A new small [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[28,38,25],"tags":[45,41,47,46,42,43,44],"class_list":["post-316","post","type-post","status-publish","format-standard","hentry","category-innovations-in-bladder-carcinoma-therapy","category-neoadjuvant-chemotherapy","category-treatment-of-muscle-invasive-bladder-cancer","tag-metastatic-bladder-cancer","tag-muscle-invasive-bladder-cancer","tag-neoadjuvant-chemo","tag-radical-cystectomy","tag-t2","tag-t3","tag-t4"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Benefit of Neoadjuvant Chemo in Micropapillary Bladder Cancer - Bladder Cancer<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/www.dralexurology.com\/bladder-cancer\/news\/benefit-neoadjuvant-chemo-micropapillary-bladder-cancer\/\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Alex Shteynshlyuger MD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"http:\/\/www.dralexurology.com\/bladder-cancer\/news\/benefit-neoadjuvant-chemo-micropapillary-bladder-cancer\/\",\"url\":\"http:\/\/www.dralexurology.com\/bladder-cancer\/news\/benefit-neoadjuvant-chemo-micropapillary-bladder-cancer\/\",\"name\":\"Benefit of Neoadjuvant Chemo in Micropapillary Bladder Cancer - Bladder Cancer\",\"isPartOf\":{\"@id\":\"http:\/\/www.dralexurology.com\/bladder-cancer\/#website\"},\"datePublished\":\"2013-12-15T13:08:02+00:00\",\"author\":{\"@id\":\"http:\/\/www.dralexurology.com\/bladder-cancer\/#\/schema\/person\/ebf5540308ae0ef79978bd465bcfc26f\"},\"breadcrumb\":{\"@id\":\"http:\/\/www.dralexurology.com\/bladder-cancer\/news\/benefit-neoadjuvant-chemo-micropapillary-bladder-cancer\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\/\/www.dralexurology.com\/bladder-cancer\/news\/benefit-neoadjuvant-chemo-micropapillary-bladder-cancer\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\/\/www.dralexurology.com\/bladder-cancer\/news\/benefit-neoadjuvant-chemo-micropapillary-bladder-cancer\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"http:\/\/www.dralexurology.com\/bladder-cancer\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Benefit of Neoadjuvant Chemo in Micropapillary Bladder Cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"http:\/\/www.dralexurology.com\/bladder-cancer\/#website\",\"url\":\"http:\/\/www.dralexurology.com\/bladder-cancer\/\",\"name\":\"Bladder Cancer\",\"description\":\"Fellowship Trained Urologist Optimizes Cancer Care\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"http:\/\/www.dralexurology.com\/bladder-cancer\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"http:\/\/www.dralexurology.com\/bladder-cancer\/#\/schema\/person\/ebf5540308ae0ef79978bd465bcfc26f\",\"name\":\"Alex Shteynshlyuger MD\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"http:\/\/www.dralexurology.com\/bladder-cancer\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/0b99ebe6e8dd34d37b0fa8940b69588a24cc2397c3a15707a5e7df31707dd5af?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/0b99ebe6e8dd34d37b0fa8940b69588a24cc2397c3a15707a5e7df31707dd5af?s=96&d=mm&r=g\",\"caption\":\"Alex Shteynshlyuger MD\"},\"url\":\"http:\/\/www.dralexurology.com\/bladder-cancer\/news\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Benefit of Neoadjuvant Chemo in Micropapillary Bladder Cancer - Bladder Cancer","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/www.dralexurology.com\/bladder-cancer\/news\/benefit-neoadjuvant-chemo-micropapillary-bladder-cancer\/","twitter_misc":{"Written by":"Alex Shteynshlyuger MD","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"http:\/\/www.dralexurology.com\/bladder-cancer\/news\/benefit-neoadjuvant-chemo-micropapillary-bladder-cancer\/","url":"http:\/\/www.dralexurology.com\/bladder-cancer\/news\/benefit-neoadjuvant-chemo-micropapillary-bladder-cancer\/","name":"Benefit of Neoadjuvant Chemo in Micropapillary Bladder Cancer - Bladder Cancer","isPartOf":{"@id":"http:\/\/www.dralexurology.com\/bladder-cancer\/#website"},"datePublished":"2013-12-15T13:08:02+00:00","author":{"@id":"http:\/\/www.dralexurology.com\/bladder-cancer\/#\/schema\/person\/ebf5540308ae0ef79978bd465bcfc26f"},"breadcrumb":{"@id":"http:\/\/www.dralexurology.com\/bladder-cancer\/news\/benefit-neoadjuvant-chemo-micropapillary-bladder-cancer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["http:\/\/www.dralexurology.com\/bladder-cancer\/news\/benefit-neoadjuvant-chemo-micropapillary-bladder-cancer\/"]}]},{"@type":"BreadcrumbList","@id":"http:\/\/www.dralexurology.com\/bladder-cancer\/news\/benefit-neoadjuvant-chemo-micropapillary-bladder-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"http:\/\/www.dralexurology.com\/bladder-cancer\/"},{"@type":"ListItem","position":2,"name":"Benefit of Neoadjuvant Chemo in Micropapillary Bladder Cancer"}]},{"@type":"WebSite","@id":"http:\/\/www.dralexurology.com\/bladder-cancer\/#website","url":"http:\/\/www.dralexurology.com\/bladder-cancer\/","name":"Bladder Cancer","description":"Fellowship Trained Urologist Optimizes Cancer Care","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"http:\/\/www.dralexurology.com\/bladder-cancer\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"http:\/\/www.dralexurology.com\/bladder-cancer\/#\/schema\/person\/ebf5540308ae0ef79978bd465bcfc26f","name":"Alex Shteynshlyuger MD","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"http:\/\/www.dralexurology.com\/bladder-cancer\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/0b99ebe6e8dd34d37b0fa8940b69588a24cc2397c3a15707a5e7df31707dd5af?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0b99ebe6e8dd34d37b0fa8940b69588a24cc2397c3a15707a5e7df31707dd5af?s=96&d=mm&r=g","caption":"Alex Shteynshlyuger MD"},"url":"http:\/\/www.dralexurology.com\/bladder-cancer\/news\/author\/admin\/"}]}},"_links":{"self":[{"href":"http:\/\/www.dralexurology.com\/bladder-cancer\/wp-json\/wp\/v2\/posts\/316","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.dralexurology.com\/bladder-cancer\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.dralexurology.com\/bladder-cancer\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.dralexurology.com\/bladder-cancer\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.dralexurology.com\/bladder-cancer\/wp-json\/wp\/v2\/comments?post=316"}],"version-history":[{"count":2,"href":"http:\/\/www.dralexurology.com\/bladder-cancer\/wp-json\/wp\/v2\/posts\/316\/revisions"}],"predecessor-version":[{"id":319,"href":"http:\/\/www.dralexurology.com\/bladder-cancer\/wp-json\/wp\/v2\/posts\/316\/revisions\/319"}],"wp:attachment":[{"href":"http:\/\/www.dralexurology.com\/bladder-cancer\/wp-json\/wp\/v2\/media?parent=316"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.dralexurology.com\/bladder-cancer\/wp-json\/wp\/v2\/categories?post=316"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.dralexurology.com\/bladder-cancer\/wp-json\/wp\/v2\/tags?post=316"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}